Immunology

Seattle BioMed Awarded $9.8 Million Grant from the National Institutes of Health to Develop Vaccine Against HIV/AIDS

Posted on

March 10, 2014

 Seattle BioMed today announced that it has received a seven year Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institute of Allergy and